Ribavirin
Ribavirin is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Hepatitis C in combination with direct-acting antivirals (e.g. sofosbuvir, simeprevir, daclatasvir, etc.) or interferon alpha or peginterferon alpha
- Respiratory syncytial virus (RSV) infection (including bronchiolitis and pneumonia) [inhalation formulation only]
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of progressive vaccinia in combination with vaccinia immune globulin (VIG)[12].
- Treatment of hemorrhagic fever.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Hepatitis C in combination with direct-acting antivirals (e.g. sofosbuvir, simeprevir, daclatasvir, etc.) or interferon alpha or peginterferon alpha
- Respiratory syncytial virus (RSV) infection (including bronchiolitis and pneumonia) [inhalation formulation only]
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of progressive vaccinia in combination with vaccinia immune globulin (VIG)[12].
- Treatment of hemorrhagic fever.
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2021 Unbound Medicine, Inc. All rights reserved